Why Curaleaf Holdings Stock Soared Nearly 20% in a Single Day

On Wednesday, the struggling cannabis industry had one of its better days, as stock prices within the sector showed considerable increases. Among these gains, one notable multi-state operator experienced a substantial rise in its share value. Curaleaf Holdings (OTC: CURLF) , which reported an almost 20% rise. This comparison stood out significantly when contrasted with the sluggish S&P 500 indices show less than 0.2% improvement.

A government representative might finalize the legalization shortly.

The significant future success of Curaleaf and similar companies heavily relies on the progression of marijuana legalization across the nation. Currently, federal authorities are considering a suggested proposal on this matter. rescheduling of the drug , moving it from its most dangerous Schedule I classification to the less severe categorization under Schedule III. This change would effectively legalize the substance across the country.

Where should you put your $1,000 investment at this moment? Our analysis group has just disclosed their thoughts on what they consider to be the 10 best stocks to buy right now. Learn More »

The possibility of this alteration appeared to pick up considerable speed on Wednesday during a confirmation hearing with the U.S. Senate's Judiciary Committee. If approved by the legislature, President Donald Trump’s appointee for the head position at the Drug Enforcement Administration (DEA), Terrance Cole, mentioned that assessing the proposition would be among his primary focuses once he assumes office at the DEA.

Even though supporters of marijuana legalization and investors in cannabis firms were initially enthusiastic when the proposal was officially presented, they've since become impatient due to its sluggish advancement through the legislative process. However, Cole’s comments suggest that this issue will receive his focused attention moving forward.

He didn't fully commit, though

Shareholders of marijuana companies (as well as those considering investing in this sector) should proceed with caution, however.

Despite the pressure from senators on the committee regarding his potential approach to rescheduling, Cole refused to pledge support for approval. He informed them that he requires further insight into "[agencies'] positions" and wants to review the scientific evidence and consult with experts before fully grasping their progress in the matter.

Should you invest $1,000 in Curaleaf right now?

Before purchasing shares in Curaleaf, keep this in mind:

The Motley Fool Stock Advisor The analyst team has recently pinpointed what they consider to be the 10 best stocks For investors looking to purchase now... Curaleaf was not among them. The 10 stocks selected have the potential to generate significant gains over the next few years.

Consider when Netflix created this list on December 17, 2004... should you have invested $1,000 following our suggestion, you’d have $607,048 !* Or when Nvidia created this list on April 15, 2005... should you have invested $1,000 following our suggestion, you’d have $668,193 !*

Now, it’s worth noting Stock Advisor 's overall average return is 880% — significantly surpassing the market with exceptional performance compared to 161% For the S&P 500 index. Ensure you don’t miss the most recent top 10 list, which becomes accessible upon joining. Stock Advisor .

Check out the 10 stocks here »

*Stock Advisor returns as of April 28, 2025

Eric Volkman The Motley Fool does not hold any shares in the stocks mentioned. The Motley Fool has no position in any of the stocks discussed. The Motley Fool maintains no stake in these companies. disclosure policy .

Share :